Due to Trump’s victory, there will be a rain of money in these stocks today, know which are the stocks which are making huge profits in intra-day?

ट्रंप की जीत से आज इन स्टॉक्स में होगी झमाझम पैसों की बारिश, जाने कौन से है इंट्रा-डे में छप्परफाड़ कमाई कराने वाले शेयर ?

Business News Desk – Donald Trump’s victory in America has filled the market with tremendous enthusiasm. Domestic equity benchmark indices BSE Sensex and Nifty 50 closed with gains of more than 1 per cent each. Nifty 50 on Wednesday closed at 24,484.05 with a gain of 1.12 per cent and Sensex closed at 80,378.13 with a rise of 1.13 per cent. However, they are still more than 6 percent below the record high. Last month, on September 27, Sensex had reached very close to 86 thousand in intra-day at 85,978.25 and Nifty had also reached close to 26300 at 26,277.35. Now talking about today, Gift Nifty is indicating to open on the red mark, i.e. the market Profit booking may be seen in. Now talking about individual stocks, the results of some companies will come today and the results of some have already come on Wednesday. Apart from these, there may be some movement in the shares today due to some corporate action. All this is being told here.

The results of these companies will come today
Mahindra & Mahindra, Lupine, Alembic Pharma, Escorts Kubota, Indian Hotels, NHPC, Aavas Financiers, Abbott India, Aditya Birla Fashion & Retail, Astral, Bajaj Electricals, Cochin Shipyard, Cummins India, Emami, Emcure Pharma, Innova Captab, IRCON International , ITD Cementation, NCC, Page Industries, Rail Vikas Nigam, SAIL, Bazaar Style Retail, Trent, Vijay Diagnostic Center and V Tech Wabag will release September quarter results.

Results of these companies came
Tata Steel Q2 (Consolidated YoY)
Tata Steel earned a consolidated profit of Rs 758.8 crore on an annual basis in the September quarter, compared to a loss of Rs 6,511.2 crore in the same quarter last year. However, revenue during this period fell by 3.25% to ₹53,904.7 crore. Talking about EBITDA, it increased by 43.9% to reach ₹6,141.3 crore and margin increased by 3.70% to 11.4%.

Power Grid Corporation of India Q2 (Consolidated YoY)
In the September quarter, Power Grid’s consolidated profit rose 0.3% year-on-year to ₹3,793 crore and revenue rose 0.09% to ₹11,277.8 crore. At the same time, EBITDA declined by 2.1% to ₹9,701.3 crore and margin fell by 1.90% to 86%.

Apollo Hospitals Enterprise Q2 (Consolidated YoY)
In the September quarter, Apollo Hospitals Enterprise’s consolidated profit increased 59% year-on-year to ₹395.7 crore, revenue increased 15.3% to ₹5,589.3 crore, EBITDA also increased 30% to ₹815.5 crore and margin increased 1.70% to ₹14.6. % Done.

Chambal Fertilizers & Chemicals Q2 (Consolidated YoY)
In the September quarter, Chambal Fertilizers & Chemicals’ consolidated profit rose 40.8% year-on-year to ₹536.4 crore, but revenue declined 19.3% to ₹4,346.2 crore. At the same time, during this period, EBITDA increased by 28.5% to ₹ 790.2 crore and margin increased by 6.80 percent to 18.2%.

Gujarat Gas Q2 (Standalone QoQ)
On a quarterly basis in July-September 2024, Gujarat Gas’ standalone profit fell 6.92% to ₹ 307 crore, revenue fell 15% to ₹ 3,781.8 and EBITDA also fell 4% to ₹ 514.2 crore. However, the margin fell by 1.60 percent to 13.6% during this period.

Novelis Q2 (YoY)
In the September quarter, Novelis’ net income fell 18% year-over-year to $128 million and adjusted EBITDA also fell 5% to $462 million. During the period, rolled product shipments increased by 1 percent to 945 kilotonnes.

India Pesticides Q2 (Consolidated YoY)
India Pesticides’ consolidated profit rose 32.9% year-on-year to ₹25.9 crore in the September quarter and revenue rose 13.3% to ₹228.8 crore.

Delta Corp Q2 (Consolidated YoY)
Delta Corp’s consolidated profit fell 61.1% to ₹27 crore and revenue fell 28.1% to ₹187.7 crore in the September quarter on a year-on-year basis.

Kansai Nerolac Paints Q2 (Consolidated YoY)
Kansai Nerolac Paints’ consolidated profit fell 31.8% year-on-year to ₹120 crore in the September quarter and revenue fell 0.3% to ₹1,951.4 crore.

Sonata Software Q2 (Consolidated QoQ)
Sonata Software’s consolidated profit rose 0.8% to ₹106.5 crore on a quarterly basis in July-September 2024, but revenue fell 14.1% to ₹2,169.8 crore during the period.

Blue Star Q2 (Consolidated YoY)
Blue Star’s consolidated profit rose 35.7% to ₹96.1 crore and revenue rose 20.4% to ₹2,276 crore in the September quarter.

Usha Martin Q2 (Consolidated YoY)
Usha Martin’s consolidated profit fell 0.2% year-on-year to ₹109.3 crore in the September quarter, but revenue grew 13.6% to ₹891.2 crore during the period.

Endurance Technologies Q2 (Consolidated YoY)
Endurance Tech’s consolidated profit rose 31.3% year-on-year to ₹203 crore in the September quarter and revenue rose 14.4% to ₹2,912.7 crore.

Avalon Technologies Q2 (Consolidated YoY)
Avalon Tech’s consolidated profit rose 140.1% year-on-year to ₹17.5 crore in the September quarter and revenue rose 36.8% to ₹275 crore.

Ren Industries Q2 (Consolidated YoY)
Rain Industries’ loss widened to ₹154.9 crore from ₹65.8 crore on a year-on-year basis in the September quarter and revenue also declined 5.4% to ₹3,934.3 crore.

Stocks to Watch: These stocks will also be in focus
wockhardt
Pharma company Wockhardt has announced the opening of QIP on 6 November. Under this, the floor price has been fixed at Rs 1,162.25 per share.

Polycab India
Polycab has made the lowest bid for the contract worth ₹1,549.66 crore from Bharat Sanchar Nigam Limited (BSNL). Under this contract, BharatNet’s middle-mile network for Package 7 (Bihar) will be developed on the Design, Build, Operate and Maintain (DBOM) model.

Sterling Tools
Sterling Tools has signed a technical cooperation agreement with Kunshan GLVAC Yuantong New Energy Technology, a wholly owned subsidiary of China’s Kunshan Guoli Electronic Technology, to manufacture advanced high-voltage direct current (HVDC) contactors and relays in the country.

innova captab
Innova Captab has received a license from the Government of Jammu and Kashmir to manufacture the medicines at its upcoming facility in Jammu.

Exit mobile version